Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Greil

Showing results (51-60 of 525) with videos related to

Pageof 53
Sort By:
Cancers|February 24, 2019
Next Generation Sequencing in AML-On the Way to Becoming a New Standard for Treatment Initiation and/or Modulation?Michael Leisch, Bettina Jansko, Nadja Zaborsky, et al.
Pharmaceuticals (Basel, Switzerland)|February 3, 2021
miRNA-Based Therapeutics in the Era of Immune-Checkpoint InhibitorsFlorian Huemer, Michael Leisch, Roland Geisberger, et al.
Cell Communication and Signaling : CCS|April 1, 2017
The double-edged sword of (re)expression of genes by hypomethylating agents: from viral mimicry to exploitation as priming agents for targeted immune checkpoint modulationFlorian Wolff, Michael Leisch, Richard Greil, et al.
Expert Opinion on Biological Therapy|October 14, 2014
Adipocyte-derived players in hematologic tumors: useful novel targets?Karin Jöhrer, Christian Ploner, Shanmugapriya Thangavadivel, et al.
Annals of Hematology|December 25, 2012
Topical evening primrose oil for reduction of bortezomib-induced skin reactionsJutta Auberger, Stefan Vogt, Georg Hopfinger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2004
Transendothelial migration of myeloma cells is increased by tumor necrosis factor (TNF)-alpha via TNF receptor 2 and autocrine up-regulation of MCP-1Karin Jöhrer, Katrin Janke, Jens Krugmann, et al.
Blood|August 30, 2008
SNP309 as predictor for sensitivity of CLL cells to the MDM2 inhibitor nutlin-3aIrina Seyfried, Sebastian Hofbauer, Markus Stoecher, et al.
Clinical Colorectal Cancer|February 14, 2026
Successful Encorafenib and Cetuximab Re-Challenge Combined With Nivolumab in BRAF V600E Mutated, Mismatch-Repair-Proficient Metastatic Colorectal Cancer - A Case Report From the AGMT mCRC RegistryIason Theodorou, Ronald Heregger, Richard Greil, et al.
Annals of Hematology|November 30, 2013
The pathogenic relevance of the prognostic markers CD38 and CD49d in chronic lymphocytic leukemiaGabriele Brachtl, Josefina Piñón Hofbauer, Richard Greil, et al.
Cancer Treatment Reviews|August 20, 2018
Remission maintenance treatment options in chronic lymphocytic leukemiaAlexander Egle, Lisa Pleyer, Thomas Melchardt, et al.
Pageof 53

Showing results (51-60 of 525) with videos related to

Sort By:
Pageof 53
Cancers|February 24, 2019
Next Generation Sequencing in AML-On the Way to Becoming a New Standard for Treatment Initiation and/or Modulation?Michael Leisch, Bettina Jansko, Nadja Zaborsky, et al.
Pharmaceuticals (Basel, Switzerland)|February 3, 2021
miRNA-Based Therapeutics in the Era of Immune-Checkpoint InhibitorsFlorian Huemer, Michael Leisch, Roland Geisberger, et al.
Cell Communication and Signaling : CCS|April 1, 2017
The double-edged sword of (re)expression of genes by hypomethylating agents: from viral mimicry to exploitation as priming agents for targeted immune checkpoint modulationFlorian Wolff, Michael Leisch, Richard Greil, et al.
Expert Opinion on Biological Therapy|October 14, 2014
Adipocyte-derived players in hematologic tumors: useful novel targets?Karin Jöhrer, Christian Ploner, Shanmugapriya Thangavadivel, et al.
Annals of Hematology|December 25, 2012
Topical evening primrose oil for reduction of bortezomib-induced skin reactionsJutta Auberger, Stefan Vogt, Georg Hopfinger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2004
Transendothelial migration of myeloma cells is increased by tumor necrosis factor (TNF)-alpha via TNF receptor 2 and autocrine up-regulation of MCP-1Karin Jöhrer, Katrin Janke, Jens Krugmann, et al.
Blood|August 30, 2008
SNP309 as predictor for sensitivity of CLL cells to the MDM2 inhibitor nutlin-3aIrina Seyfried, Sebastian Hofbauer, Markus Stoecher, et al.
Clinical Colorectal Cancer|February 14, 2026
Successful Encorafenib and Cetuximab Re-Challenge Combined With Nivolumab in BRAF V600E Mutated, Mismatch-Repair-Proficient Metastatic Colorectal Cancer - A Case Report From the AGMT mCRC RegistryIason Theodorou, Ronald Heregger, Richard Greil, et al.
Annals of Hematology|November 30, 2013
The pathogenic relevance of the prognostic markers CD38 and CD49d in chronic lymphocytic leukemiaGabriele Brachtl, Josefina Piñón Hofbauer, Richard Greil, et al.
Cancer Treatment Reviews|August 20, 2018
Remission maintenance treatment options in chronic lymphocytic leukemiaAlexander Egle, Lisa Pleyer, Thomas Melchardt, et al.
Pageof 53